Price to Earnings (P/E)
since 2005
Paying user area
Try for free
DexCom Inc. pages available for free this week:
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to DexCom Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
DexCom Inc., P/E, long-term trends, calculation
| P/E | = | Share price1, 2, 3 | ÷ | Earnings per share1 (EPS) | EPS1 | = | Net income (loss)1 (in thousands) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 9, 2023 | = | ÷ | = | ÷ | |||||||
| Feb 14, 2022 | = | ÷ | = | ÷ | |||||||
| Feb 11, 2021 | = | ÷ | = | ÷ | |||||||
| Feb 13, 2020 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2019 | = | ÷ | = | ÷ | |||||||
| Feb 27, 2018 | = | ÷ | = | ÷ | |||||||
| Feb 28, 2017 | = | ÷ | = | ÷ | |||||||
| Feb 23, 2016 | = | ÷ | = | ÷ | |||||||
| Feb 25, 2015 | = | ÷ | = | ÷ | |||||||
| Feb 20, 2014 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2013 | = | ÷ | = | ÷ | |||||||
| Feb 23, 2012 | = | ÷ | = | ÷ | |||||||
| Mar 3, 2011 | = | ÷ | = | ÷ | |||||||
| Mar 9, 2010 | = | ÷ | = | ÷ | |||||||
| Mar 5, 2009 | = | ÷ | = | ÷ | |||||||
| Mar 11, 2008 | = | ÷ | = | ÷ | |||||||
| Feb 27, 2007 | = | ÷ | = | ÷ | |||||||
| Feb 27, 2006 | = | ÷ | = | ÷ |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of DexCom Inc. Annual Report.
- Share Price Trend
- The share price shows a volatile pattern initially, with a decline from $4.25 in 2006 to a low of $0.82 in 2009. Following this period, there is a general upward trend from 2010 onwards, peaking sharply in 2021 at $102.55. After a slight dip in 2022 to $101.75, the price recovers modestly to $107.24 in 2023. Overall, the share price experienced substantial growth over the long term, particularly in the last decade.
- Earnings Per Share (EPS) Trend
- EPS remained negative from 2006 through 2019, indicating consistent losses during this period. Losses gradually decreased from -$0.30 in 2006 to a minimum of -$0.07 in 2014 but then showed some fluctuations with losses increasing again around 2019 (-$0.35). Notably, in 2020, the company reported a positive EPS of $0.28, followed by a significant increase to $1.28 in 2021. EPS fluctuated in 2022 and 2023, with values of $0.40 and $0.88 respectively, suggesting the company turned profitable and began to achieve earnings growth in recent years.
- Price-to-Earnings (P/E) Ratio Analysis
- P/E data is available only from 2020 onwards, coinciding with the company turning profitable. The P/E ratio exhibited high volatility, starting at 228.49 in 2020, dropping to 79.93 in 2021, then spiking to 255.37 in 2022 before falling again to 121.45 in 2023. These elevated P/E ratios indicate investor expectations of high future growth, although the variability also reflects market uncertainty or earnings fluctuations.
- Overall Insights
- The company's financial trajectory illustrates a turnaround from prolonged losses to profitability starting in 2020. The share price appreciation is consistent with this recovery, showing strong investor confidence particularly from 2013 onward and accelerating post-2019. Despite profitability, the high and fluctuating P/E ratios imply that valuation remains sensitive to market sentiment and earnings performance. The data suggests the company is in a growth phase but still subject to substantial market dynamics affecting its valuation metrics.
Comparison to Competitors
DexCom Inc., P/E, long-term trends, comparison to competitors
| DexCom Inc. | Abbott Laboratories | CVS Health Corp. | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|---|
| Feb 9, 2023 | |||||||
| Feb 14, 2022 | |||||||
| Feb 11, 2021 | |||||||
| Feb 13, 2020 | |||||||
| Feb 21, 2019 | |||||||
| Feb 27, 2018 | |||||||
| Feb 28, 2017 | |||||||
| Feb 23, 2016 | |||||||
| Feb 25, 2015 | |||||||
| Feb 20, 2014 | |||||||
| Feb 21, 2013 | |||||||
| Feb 23, 2012 | |||||||
| Mar 3, 2011 | |||||||
| Mar 9, 2010 | |||||||
| Mar 5, 2009 | |||||||
| Mar 11, 2008 | |||||||
| Feb 27, 2007 | |||||||
| Feb 27, 2006 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
DexCom Inc., P/E, long-term trends, comparison to sector (health care equipment & services)
| DexCom Inc. | Health Care Equipment & Services | |
|---|---|---|
| Feb 9, 2023 | ||
| Feb 14, 2022 | ||
| Feb 11, 2021 | ||
| Feb 13, 2020 | ||
| Feb 21, 2019 | ||
| Feb 27, 2018 | ||
| Feb 28, 2017 | ||
| Feb 23, 2016 | ||
| Feb 25, 2015 | ||
| Feb 20, 2014 | ||
| Feb 21, 2013 | ||
| Feb 23, 2012 | ||
| Mar 3, 2011 | ||
| Mar 9, 2010 | ||
| Mar 5, 2009 | ||
| Mar 11, 2008 | ||
| Feb 27, 2007 | ||
| Feb 27, 2006 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
DexCom Inc., P/E, long-term trends, comparison to industry (health care)
| DexCom Inc. | Health Care | |
|---|---|---|
| Feb 9, 2023 | ||
| Feb 14, 2022 | ||
| Feb 11, 2021 | ||
| Feb 13, 2020 | ||
| Feb 21, 2019 | ||
| Feb 27, 2018 | ||
| Feb 28, 2017 | ||
| Feb 23, 2016 | ||
| Feb 25, 2015 | ||
| Feb 20, 2014 | ||
| Feb 21, 2013 | ||
| Feb 23, 2012 | ||
| Mar 3, 2011 | ||
| Mar 9, 2010 | ||
| Mar 5, 2009 | ||
| Mar 11, 2008 | ||
| Feb 27, 2007 | ||
| Feb 27, 2006 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).